A phase I Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 19 Oct 2015
At a glance
- Drugs Benvitimod (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Pharmacokinetics
- 19 Oct 2015 New trial record